Current Issue October 2011, Vol. 9, No. 2

• Progression-free survival as an end-point in clinical trials of biotherapeutic agents
  December 2007 (Vol. 5 | No. 9 | Pages 23-28)

  Lothar Bergmann, Steven Hirschfeld, Charles Morris, Sergio Palmeri, Andrew Stone, Biotherapy Development Association (BDA)

  • Abstract
  • Full Text
  • PDF (141 KB)
• The 7th Edition of the TNM Classification for Lung Cancer: Proposals from the IASLC Staging Project
  September 2007 (Vol. 5 | No. 5 | Pages 15-22)

  Peter Goldstraw

  • Abstract
  • Abstract + References
  • PDF (152 KB)
• Prognostic factors in advanced renal cell cancer
  October 2008 (Vol. 6 | No. 14 | Pages 35-37)

  Camillo Porta, Ilaria Imarisio, Chiara Paglino, Elisa Ferraris, Mario Mensi, Bruno Rovereto

  • Abstract
  • Full Text
  • PDF (97 KB)
• G6 Clinical activity observed in a phase I dose escalation trial of an oral c-met and ALK inhibitor, PF-02341066
  September 2009 (Vol. 7 | No. 3 | Page 8)

  E.L. Kwak, D.R. Camidge, J. Clark, G.I. Shapiro, R.G. Maki, M.J. Ratain, B. Solomon, Y. Bang, S. Ou, R. Salgia

  • PDF (48 KB)
• Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy
  November 2006 (Vol. 4 | No. 11 | Pages 45-51)

  Damijan Miklavcic, Selma Corovic, Gorazd Pucihar, Natasa Pavselj

  • Abstract
  • Full Text
  • PDF (685 KB)

Most Read lists are compiled every quarter.